SEC Filings

SEC Filings

Filing date	Description	Form	View
Dec 30, 2016	FWP	FWP	View HTML 0001193125-16-807685.pdf 0001193125-16-807685.rtf
Dec 29, 2016	Amended Registration statement for face-amount certificate companies	S-1/A	View HTML 0001193125-16-807318.pdf 0001193125-16-807318.rtf 0001193125-16-807318.xls
Dec 28, 2016	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-16-804999.pdf 0001193125-16-804999.rtf 0001193125-16-804999.xls
Dec 23, 2016	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-16-802787.pdf 0001193125-16-802787.rtf 0001193125-16-802787.xls
Dec 20, 2016	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-16-798635.pdf 0001193125-16-798635.rtf 0001193125-16-798635.xls
Dec 13, 2016	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-16-790936.pdf 0001193125-16-790936.rtf 0001193125-16-790936.xls
Dec 05, 2016	Additional proxy soliciting materials - definitive	DEFA14A	View HTML 0001193125-16-785242.pdf 0001193125-16-785242.rtf 0001193125-16-785242.xls
Dec 05, 2016	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-16-785241.pdf 0001193125-16-785241.rtf 0001193125-16-785241.xls
Nov 22, 2016	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-16-774905.pdf 0001193125-16-774905.rtf 0001193125-16-774905.xls
Nov 22, 2016	Additional proxy soliciting materials - definitive	DEFA14A	View HTML 0001193125-16-774906.pdf 0001193125-16-774906.rtf 0001193125-16-774906.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE